Glutathione transferases as targets for cancer therapy

Paolo Ruzza; Antonio Rosato; Carlo Riccardo Rossi; Maura Floreani; Luigi Quintieri

doi:10.2174/187152009789056895

Glutathione transferases as targets for cancer therapy

Paolo Ruzza, Antonio Rosato, Carlo Riccardo Rossi, Maura Floreani, Luigi Quintieri

Istituto Oncologico Veneto

Research output: Contribution to journal › Article › peer-review

Abstract

Besides catalyzing the inactivation of various electrophile-producing anticancer agents via conjugation to the tripeptide glutathione, some cytosolic proteins belonging to the glutathione transferase (formerly glutatione-S- transferase; GST) superfamily are emerging as negative modulators of stress/drug-induced cell apoptosis through the interaction with specific signaling kinases. In addition, several data link the overexpression of some GSTs, in particular GSTP1-1, to both natural and acquired resistance to various structurally unrelated anticancer drugs. Tumor overexpression of these proteins has provided a rationale for the search of GST inhibitors and GST-activated cytotoxic prodrugs. In the present review we discuss the current structural and pharmacological knowledge of both types of GST-targeting compounds.

Original language	English
Pages (from-to)	763-777
Number of pages	15
Journal	Anti-Cancer Agents in Medicinal Chemistry
Volume	9
Issue number	7
DOIs	https://doi.org/10.2174/187152009789056895
Publication status	Published - 2009

Keywords

Anticancer drug resistance
Cancer chemotherapy
GST inhibitors
GST-activated prodrugs

ASJC Scopus subject areas

Cancer Research
Molecular Medicine
Pharmacology

Access to Document

10.2174/187152009789056895

Fingerprint Dive into the research topics of 'Glutathione transferases as targets for cancer therapy'. Together they form a unique fingerprint.

Cite this

@article{43155cdf77aa4313917f45b0f9322234,

title = "Glutathione transferases as targets for cancer therapy",

abstract = "Besides catalyzing the inactivation of various electrophile-producing anticancer agents via conjugation to the tripeptide glutathione, some cytosolic proteins belonging to the glutathione transferase (formerly glutatione-S- transferase; GST) superfamily are emerging as negative modulators of stress/drug-induced cell apoptosis through the interaction with specific signaling kinases. In addition, several data link the overexpression of some GSTs, in particular GSTP1-1, to both natural and acquired resistance to various structurally unrelated anticancer drugs. Tumor overexpression of these proteins has provided a rationale for the search of GST inhibitors and GST-activated cytotoxic prodrugs. In the present review we discuss the current structural and pharmacological knowledge of both types of GST-targeting compounds.",

keywords = "Anticancer drug resistance, Cancer chemotherapy, GST inhibitors, GST-activated prodrugs",

author = "Paolo Ruzza and Antonio Rosato and Rossi, {Carlo Riccardo} and Maura Floreani and Luigi Quintieri",

year = "2009",

doi = "10.2174/187152009789056895",

language = "English",

volume = "9",

pages = "763--777",

journal = "Anti-Cancer Agents in Medicinal Chemistry",

issn = "1871-5206",

publisher = "Bentham Science Publishers B.V.",

number = "7",

}

TY - JOUR

T1 - Glutathione transferases as targets for cancer therapy

AU - Ruzza, Paolo

AU - Rosato, Antonio

AU - Rossi, Carlo Riccardo

AU - Floreani, Maura

AU - Quintieri, Luigi

PY - 2009

Y1 - 2009

N2 - Besides catalyzing the inactivation of various electrophile-producing anticancer agents via conjugation to the tripeptide glutathione, some cytosolic proteins belonging to the glutathione transferase (formerly glutatione-S- transferase; GST) superfamily are emerging as negative modulators of stress/drug-induced cell apoptosis through the interaction with specific signaling kinases. In addition, several data link the overexpression of some GSTs, in particular GSTP1-1, to both natural and acquired resistance to various structurally unrelated anticancer drugs. Tumor overexpression of these proteins has provided a rationale for the search of GST inhibitors and GST-activated cytotoxic prodrugs. In the present review we discuss the current structural and pharmacological knowledge of both types of GST-targeting compounds.

AB - Besides catalyzing the inactivation of various electrophile-producing anticancer agents via conjugation to the tripeptide glutathione, some cytosolic proteins belonging to the glutathione transferase (formerly glutatione-S- transferase; GST) superfamily are emerging as negative modulators of stress/drug-induced cell apoptosis through the interaction with specific signaling kinases. In addition, several data link the overexpression of some GSTs, in particular GSTP1-1, to both natural and acquired resistance to various structurally unrelated anticancer drugs. Tumor overexpression of these proteins has provided a rationale for the search of GST inhibitors and GST-activated cytotoxic prodrugs. In the present review we discuss the current structural and pharmacological knowledge of both types of GST-targeting compounds.

KW - Anticancer drug resistance

KW - Cancer chemotherapy

KW - GST inhibitors

KW - GST-activated prodrugs

UR - http://www.scopus.com/inward/record.url?scp=73449121064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73449121064&partnerID=8YFLogxK

U2 - 10.2174/187152009789056895

DO - 10.2174/187152009789056895

M3 - Article

C2 - 19538171

AN - SCOPUS:73449121064

VL - 9

SP - 763

EP - 777

JO - Anti-Cancer Agents in Medicinal Chemistry

JF - Anti-Cancer Agents in Medicinal Chemistry

SN - 1871-5206

IS - 7

ER -

Glutathione transferases as targets for cancer therapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this